Key result
Patients undergoing total hip replacement in high-transfusion hospitals had higher odds of receiving RBC transfusions compared to average-transfusion hospitals (AOR 2.41; 95% CI 1.89-3.09).
Why the study?
Does the hospital of treatment affect the likelihood of receiving blood transfusions in patients undergoing major noncardiac surgery?
Population
Patients undergoing major noncardiac surgery at academic medical centers in the United States.
Comparison
Treatment at high-transfusion hospitals vs Treatment at average-transfusion or…
Design
Cohort
Follow-up
perioperative
Authors
Loading...
Hospital variation drives transfusion odds in hip replacement independent of risk; leaves open whether standardization improves outcomes.
Observational
Yes
Does the hospital of treatment affect the likelihood of receiving blood transfusions in patients undergoing major noncardiac surgery?
Effect estimate: AOR 2.41 (95% CI 1.89-3.09)
There is dramatic hospital-level variability in perioperative blood transfusion rates for major noncardiac surgery at US academic medical centers, independent of patient risk factors.
Qian et al. (2012) conducted an observational in Major noncardiac surgery. Treatment in high-transfusion hospitals vs. Treatment in average-transfusion hospitals was evaluated on Use of allogeneic RBC, FFP, and platelet transfusions (AOR 2.41, 95% CI 1.89-3.09). Patients undergoing total hip replacement in high-transfusion hospitals had higher odds of receiving RBC transfusions compared to average-transfusion hospitals (AOR 2.41; 95% CI 1.89-3.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: